Alcohol Disease Burden Reduction Academy

The Alcohol Disease Burden Reduction Academy is a pioneering initiative introduced in the Nigerian healthcare system on May 2, 2026, by Vastovers Partners Ltd. As the first program of its kind, its aim is to advance the leadership of healthcare professionals in reducing alcohol-related diseases. The target healthcare professionals include physicians and pharmacists.

This program serves as a cornerstone for clinical advocacy and professional development among healthcare practitioners, striving to reduce the hidden health burden of alcohol consumption, a topic that is often overlooked in Nigeria. No amount of alcohol consumption is safe; it is a silent killer that leads to both long-term and short-term side effects such as hangovers, acid reflux, gastrointestinal cancers, neurological issues, cardiovascular diseases, and damage to the kidneys and liver. This burden quietly deteriorates the health of our population, and by neglecting this issue, healthcare professionals can change patient management and treatment outcomes simply by asking patients about their alcohol use.

Thus, this initiative was created to promote awareness regarding the dangers of alcohol consumption and the necessity of identifying alcohol users during clinical visits and admissions through standardized assessment techniques. The program emphasizes patient-centered strategies to reduce alcohol-related diseases and provides clinical support for identified patients through counseling, behavioral therapy to help them stop or reduce their alcohol consumption, and medications to alleviate the imminent side effects of alcohol.

The driving force behind this initiative is the Managing Director and Founder of Vastovers Group, Pharmacist (Dr.) Vast Emordi. The program is held monthly for physicians and pharmacists, with the inaugural edition in May 2026 featuring numerous doctors in a lecture series presented by consultant physicians and gastroenterologists specializing in the field.

About Vastovers: Vastovers Company was established in January 2016 and has since diversified its operations across various sectors. Vastovers Partners is a collective of healthcare practitioners associated with Vastovers, unified by a shared commitment to fostering innovation and leadership within the healthcare domain.

Under the banner of Vastovers Drugs and Allied Products Ltd, the company has secured registered trademark ownership for a range of lifestyle medications, while also distributing essential health solutions. Over the past decade, Vastovers Drugs and Allied Products has solidified its reputation as a trusted entity within the Nigerian healthcare sector, committed to addressing clinical needs and enhancing access to lifestyle medications.

Strategic Partnerships
The Academy is a collaborative effort designed for the continuous professional growth of the Nigerian medical and pharmaceutical community. It partners with organizations such as the Medical and Dental Council of Nigeria (MDCN), the Society of Family Physicians of Nigeria (SOFPON)-FCT KEFFI Chapter, the Association of Community Pharmacists of Nigeria, the Pharmacy Council of Nigeria, and the Pharmaceutical Society of Nigeria.

The program has a national vision to reach over 50% of registered doctors and pharmacists in active service across all 35 states of Nigeria and the Federal Capital Territory (FCT) by 2030, encouraging them to become champions of this initiative.

The Pathophysiology Summary of Alcohol: Acetaldehyde Toxicity

Alcohol significantly contributes to long-term health burdens due to its metabolic consequences. When consumed, it is metabolized into acetaldehyde, a highly toxic substance and known carcinogen. This toxicity can lead to neurological damage, gastrointestinal risks, organ failure (including liver cirrhosis), and immune suppression. Understanding this clinical reality is the first step toward effective intervention.

A Brief of Public Health Landscape in Nigeria Regarding Alcohol Consumption

With an adult population of approximately 128.4 million and a domestic alcohol market valued at over 2.18 trillion naira, the accessibility of alcohol poses a significant challenge to public health. According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in 2018, 8 out of 10 adults consume alcohol at some point in their lives. This statistic highlights a significant number of adults who may require health attention related to alcohol consumption. While the alcohol market contributes to the economy, the resulting health burden—ranging from organ damage to increased hospital visits—places an urgent demand on the healthcare system, necessitating strong leadership from physicians and pharmacists.

Addressing Critical Gaps in Patient Care

Standard medical advice often concludes with “drink responsibly,” which frequently fails to yield long-term results. The Academy has identified three critical gaps in the current healthcare system:

1. Advocacy Gap: A lack of national awareness about alcohol-related issues.
2. Screening Gap: A lack of routine assessments for alcohol use.
3. Medication Gap: Minimal awareness of pharmacotherapy options that can protect vital organs.

Currently, the Nigerian government’s focus is on enacting regulations for manufacturers and generating tax revenue, with no stringent laws regulating alcohol consumption. As a result, there is a pressing need for healthcare professionals who interact directly with patients to drive awareness and help close these gaps.

To safeguard public health, physicians and pharmacists are encouraged to adopt a proactive three-step approach, as no single strategy is sufficient:

1. Patient Identification: Implement mandatory alcohol screenings for all adult patients during routine consultations.

2. Patient Counseling: Provide evidence-based counseling on the health risks associated with alcohol consumption.

3. Use of Medication: Utilize lifestyle medications like ACHOLCARE and ACHOLSAFE to mitigate the overall impact of alcohol on the body. ACHOLCARE helps reduce hangovers and hyperacidity, while ACHOLSAFE improves liver function.

The program has seen tangible success in reducing alcohol-related diseases, as more healthcare professionals are now complying with and championing this advocacy in their practices.